Condition: Hyperlipidemias · Diabetes · Depression · Sponsor: University of Massachusetts, Worcester
The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it aims to answer is: Does the WE CARE SDOH screening and referral intervention applying an antiracism lens informed implementation strategies have the potential to reduce racial/ethnic health inequities in chronic diseases for minoritized patients?
This description comes directly from the study's public registry record.
Arvin Garg · 4103363261 · arvin.garg@umassmemorial.org
Jennifer Hazelton · 9783370340 · jennifer.hazelton@umassmed.edu
Always discuss trial participation with your own doctor first.
| UMass Memorial Medical Center - Hahnemann Campus | Worcester, Massachusetts, United States | Recruiting |
| Family Health Center of Worcester | Worcester, Massachusetts, United States | Not Yet Recruiting |
| UMass Memorial Medical Center -Benedict Family Medicine Clinic | Worcester, Massachusetts, United States | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06903897